What is Attention Deficit-Hyperactivity Disorder?
Attention deficit-hyperactivity disorder (ADHD) is a neurobehavioral disorder that affects 3-5 percent of all American children. It interferes with a person's ability to stay on a task and to exercise age-appropriate inhibition (cognitive alone or both cognitive and behavioral). Some of the warning signs of ADHD include failure to listen to instructions, inability to organize oneself and school work, fidgeting with hands and feet, talking too much, leaving projects, chores and homework unfinished, and having trouble paying attention to and responding to details. There are several types of ADHD: a predominantly inattentive subtype, a predominantly hyperactive-impulsive subtype, and a combined subtype. ADHD is usually diagnosed in childhood, although the condition can continue into the adult years.
Is there any treatment?
The usual course of treatment may include medications such as methylphenidate (Ritalin) or dextroamphetamine (Dexedrine), which are stimulants that decrease impulsivity and hyperactivity and increase attention. Most experts agree that treatment for ADHD should address multiple aspects of the individual's functioning and should not be limited to the use of medications alone. Treatment should include structured classroom management, parent education (to address discipline and limit-setting), and tutoring and/or behavioral therapy for the child.
What is the prognosis?
There is no cure for ADHD. Children with the disorder seldom outgrow it; however, some may find adaptive ways to accommodate the ADHD as they mature.
What research is being done?
Several components of the NIH support research on developmental disorders such as ADHD. Research programs of the NINDS, the National Institute of Mental Health (NIMH), and the National Institute of Child Health and Human Development (NICHD) seek to address unanswered questions about the causes of ADHD, as well as to improve diagnosis and treatment.
NIH Patient Recruitment for Attention Deficit-Hyperactivity Disorder Clinical Trials
* At NIH Clinical Center
* Throughout the U.S. and Worldwide
CHADD - Children and Adults with Attention-Deficit/Hyperactivity Disorder
8181 Professional Place
Landover, MD 20785
Tel: 301-306-7070 800-233-4050
Attention Deficit Disorder Association (ADDA)
P.O. Box 543
Pottstown, PA 19464
Learning Disabilities Association of America
4156 Library Road
Pittsburgh, PA 15234-1349
National Center for Learning Disabilities
381 Park Avenue South
New York, NY 10016
Tel: 212-545-7510 888-575-7373
National Institute of Mental Health (NIMH)
National Institutes of Health, DHHS
6001 Executive Blvd. Rm. 8184, MSC 9663
Bethesda, MD 20892-9663
Tel: 301-443-4513/866-415-8051 301-443-8431 (TTY)
Related NINDS Publications and Information
*Methylphenidate and Clonidine Help Children With ADHD and Tics
April 2002 news summary on a clinical trial of methylphenidate and clonidine in children with ADHD and tics.